US5631148A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ribozymes with product ejection by strand displacement
Assignee: Novartis Vaccines and Diagnostics Inc
•
Filing: 1994-04-22
•
Granted: 1997-05-20
•
Expires: 2014-04-22
Abstract
Abstract Ribozymes designed to provide improved rates of catalytic turnover are described. The compounds of this invention comprise a catalytic region, at least one substrate binding region, and at least one displaceable antisense arm, whereby the rate of release of the endonuclease cleavage fragments is enhanced. A method to make such ribozymes is also described.
Inventors
- 👤 Michael S. Urdea
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 07:34
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; A; A61; A61K; A61K38/00; C12N2310/00; C12N2310/10; C12N2310/11; C12N2310/111; C12N2310/12; C12N2310/121; C12N2310/122; C12N2310/50; C12N2310/53
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
126 words
A synthetic ribozyme polynucleotide having a first end and a second end, comprising from said first end to said second end: a catalytic region having endonuclease activity specific for a target polynucleotide sequence of a substrate; a first substrate binding region linked to said catalytic region, said first substrate binding region comprising a first competitive binding nucleotide sequence capable of forming a first hybrid with said substrate; and a first displaceable antisense arm linked to said first substrate binding region, wherein said first displaceable antisense arm comprises a first stabilization region and a second stabilization region, said first stabilization region being capable of hybridizing with said second stabilization region, and a first displacement region capable of forming a second hybrid with said competitive binding nucleotide sequence.
Claim 2
Dependent Claim
126 words
A synthetic ribozyme polynucleotide having a first end and a second end, comprising from said first end to said second end: a catalytic region having endonuclease activity specific for a target polynucleotide sequence of a substrate; a first substrate binding region linked to said catalytic region, said first substrate binding region comprising a first competitive binding nucleotide sequence capable of forming a first hybrid with said substrate; and a first displaceable antisense arm linked to said first substrate binding region, wherein said first displaceable antisense arm comprises a first stabilization region and a second stabilization region, said first stabilization region being capable of hybridizing with said second stabilization region, and a first displacement region capable of forming a second hybrid with said competitive binding nucleotide sequence.
Claim 3
Dependent Claim
15 words
The synthetic ribozyme polynucleotide of claim 1 wherein said synthetic ribozyme is a unitary molecule.
Claim 4
Dependent Claim
62 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first displaceable antisense arm comprises a first fragment containing said first stabilization region and a second fragment containing said second stabilization region, wherein said first fragment is linked to said first substrate binding region, and wherein said second fragment is associated only by noncovalent bonds between said first and said second stabilization regions.
Claim 5
Dependent Claim
26 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first stabilization region and said first competitive binding nucleotide sequence are separated by at least one nucleotide.
Claim 6
Dependent Claim
23 words
The synthetic ribozyme polynucleotide of claim 1, further comprising a second substrate binding region linked to said catalytic region at said first end.
Claim 7
Dependent Claim
21 words
The synthetic ribozyme polynucleotide of claim 5, further comprising a second displaceable antisense arm linked to said second substrate binding region.
Claim 8
Dependent Claim
23 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first substrate binding region is directly linked by covalent bonds to said catalytic region.
Claim 9
Dependent Claim
25 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first displaceable antisense arm is directly linked by covalent bonds to said first substrate binding region.
Claim 10
Dependent Claim
25 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first substrate binding region is indirectly linked by an intervening polynucleotide region to said catalytic region.
Claim 11
Dependent Claim
27 words
The synthetic ribozyme polynucleotide of claim 1 wherein said first displaceable antisense arm is indirectly linked by an intervening polynucleotide region to said first substrate binding region.
Claim 12
Dependent Claim
17 words
The synthetic ribozyme polynucleotide of claim 1 wherein said synthetic ribozyme polynucleotide is of the hammerhead structure.
Claim 13
Dependent Claim
17 words
The synthetic ribozyme polynucleotide of claim 1 wherein said synthetic ribozyme polynucleotide is of the hairpin structure.
Claim 14
Dependent Claim
14 words
A composition which comprises the synthetic ribozyme polynucleotide of claim 1 in a carrier.
Claim 15
Dependent Claim
24 words
A synthetic ribozyme polynucleotide comprising at least one displaceable antisense arm, wherein the sugar-phosphate backbone of said synthetic ribozyme polynucleotide has been chemically altered.
Claim 16
Dependent Claim
24 words
A synthetic ribozyme polynucleotide comprising at least one displaceable antisense arm, wherein the sugar-phosphate backbone of said synthetic ribozyme polynucleotide has been chemically altered.
Claim 17
Dependent Claim
17 words
The synthetic ribozyme polynucleotide of claim 14 wherein at least one ribonucleotide is replaced with a deoxynucleotide.
Claim 18
Dependent Claim
17 words
The synthetic ribozyme polynucleotide of claim 14 wherein at least one ribonucleotide is modified at the 2'-position.
Claim 19
Dependent Claim
25 words
The synthetic ribozyme polynucleotide of claim 16 wherein said at least one ribonucleotide is selected from a group consisting of 2'-fluoro, 2'-amino, 2'-O-alkyl, and 2'-O-allyl.
Claim 20
Dependent Claim
15 words
The synthetic ribozyme polynucleotide of claim 17 wherein said at least one ribonucleotide is 2'-O-methyl.
Claim 21
Dependent Claim
16 words
The synthetic ribozyme polynucleotide of claim 14 wherein selected ribonucleotides of said sugar-phosphate backbone are phosphorothionated.
Claim 22
Independent Claim
151 words
A method for producing synthetic ribozyme polynucleotides, comprising the steps of: constructing at least one set of synthetic ribozyme oligonucleotides comprising variable length substrate binding regions and displaceable antisense arm regions, and further comprising an inactivated catalytic site; constructing a desired substrate; contacting said set of synthetic oligonucleotides with said substrate at a temperature which is less than a preselected temperature; capturing complexes of said substrate and said oligonucleotides; subjecting said complexes to said preselected temperature; capturing and amplifying any oligonucleotides released at said preselected temperature; repeating the steps of constructing synthetic ribozyme oligonucleotides, contacting with substrate, capturing complexes, subjecting complexes to said preselected temperature, and capturing and amplifying released complexes, until a constant binding and release is found; cloning, isolating, and sequencing any oligonucleotides released after said constant binding and release is achieved; and activating the catalytic sites of any oligonucleotides released after said constant binding and release is achieved.
Claim 23
Independent Claim
151 words
A method for producing synthetic ribozyme polynucleotides, comprising the steps of: constructing at least one set of synthetic ribozyme oligonucleotides comprising variable length substrate binding regions and displaceable antisense arm regions, and further comprising an inactivated catalytic site; constructing a desired substrate; contacting said set of synthetic oligonucleotides with said substrate at a temperature which is less than a preselected temperature; capturing complexes of said substrate and said oligonucleotides; subjecting said complexes to said preselected temperature; capturing and amplifying any oligonucleotides released at said preselected temperature; repeating the steps of constructing synthetic ribozyme oligonucleotides, contacting with substrate, capturing complexes, subjecting complexes to said preselected temperature, and capturing and amplifying released complexes, until a constant binding and release is found; cloning, isolating, and sequencing any oligonucleotides released after said constant binding and release is achieved; and activating the catalytic sites of any oligonucleotides released after said constant binding and release is achieved.
Claim 24
Independent Claim
152 words
A method of cleaving a target nucleotide sequence of a substrate, comprising the steps of: providing said substrate; providing a synthetic ribozyme polynucleotide having a first end and a second end, comprising from said first end to said second end a catalytic region having endonuclease activity specific for said target polynucleotide sequence and a first substrate binding region linked to said catalytic region, said substrate binding region further comprising a first competitive binding nucleotide sequence capable of forming a first hybrid with said substrate, and a first displaceable antisense arm linked to said substrate binding region, said first displaceable antisense arm further comprising a first stabilization region, a second stabilization region, and a first displacement region capable of forming a second hybrid with said first competitive binding nucleotide sequence; and contacting said synthetic ribozyme polynucleotide and said substrate to allow said catalytic region to cleave said substrate at said target nucleotide sequence.
Claim 25
Independent Claim
152 words
A method of cleaving a target nucleotide sequence of a substrate, comprising the steps of: providing said substrate; providing a synthetic ribozyme polynucleotide having a first end and a second end, comprising from said first end to said second end a catalytic region having endonuclease activity specific for said target polynucleotide sequence and a first substrate binding region linked to said catalytic region, said substrate binding region further comprising a first competitive binding nucleotide sequence capable of forming a first hybrid with said substrate, and a first displaceable antisense arm linked to said substrate binding region, said first displaceable antisense arm further comprising a first stabilization region, a second stabilization region, and a first displacement region capable of forming a second hybrid with said first competitive binding nucleotide sequence; and contacting said synthetic ribozyme polynucleotide and said substrate to allow said catalytic region to cleave said substrate at said target nucleotide sequence.
Claim 26
Dependent Claim
14 words
The method of claim 21 wherein said synthetic ribozyme polynucleotide is a unitary molecule.
Claim 27
Dependent Claim
60 words
The method of claim 21 wherein said first displaceable antisense arm comprises a first fragment containing said first stabilization region and a second fragment containing said second stabilization region, wherein said first fragment is linked to said first substrate binding region, and wherein said second fragment is associated only by noncovalent bonds between said first and said second stabilization regions.
Claim 28
Dependent Claim
24 words
The method of claim 21 wherein said first stabilization region and said first competitive binding nucleotide sequence are separated by at least one nucleotide.
Claim 29
Dependent Claim
21 words
The method of claim 21, further comprising a second substrate binding region linked to said catalytic region at said first end.
Claim 30
Dependent Claim
19 words
The method of claim 25, further comprising a second displaceable antisense arm linked to said second substrate binding region.
Claim 31
Dependent Claim
15 words
The method of claim 21 wherein said synthetic ribozyme polynucleotide is of the hammerhead structure.
Claim 32
Dependent Claim
15 words
The method of claim 21 wherein said synthetic ribozyme polynucleotide is of the hairpin structure.
References Cited (Backward Citations)
US4818680A
Cited
US4987071A
Cited
US5037746A
Cited
US5093246A
Cited
US5116742A
Cited
US5254678A
Cited
US5168053A
Cited
US5144019A
Cited
US5225347A
Cited
US5225337A
Cited
US5436330A
Cited
US5180818A
Cited
WO1992013070A1
Cited
WO1994001550A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-05-19 | 2000-11-18 | 2001-05-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-05-19 | 2004-11-18 | 2005-05-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-05-19 | 2008-11-18 | 2009-05-20 | $7700.00 | Window Closed / Lapsed |